Crack-cocaine use is prevalent in numerous countries, yet concentrated primarily–largely
within urban contexts–in the Northern and Southern regions of the Americas. It is associated …

Background Cannabinoids may have an important therapeutic potential for the treatment of
dependence on crack cocaine. Cannabidiol (CBD), in particular, has anxiolytic …

Background Cannabidiol (CBD) is one of the major constituents of Cannabis sativa L. that
lacks psychotomimetic and rewarding properties and inhibits the rewarding and reinforcing …

Drug addiction is a chronically relapsing disorder characterized by the compulsive desire to
use drugs and a loss of control over consumption. Cannabidiol (CBD), the second most …

Background No effective pharmacotherapies exist for the treatment of crack cocaine use
disorders. Emerging data suggests that cannabinoids may play a role in reducing cocaine …

Objective The drug poisoning crisis throughout North America necessitates novel harm
reduction approaches. Emerging evidence suggests that cannabidiol (CBD) may have some …

Multiple cannabinoids derived from the marijuana plant have potential therapeutic benefits
but most have not been well investigated, despite the widespread legalization of medical …

Currently, there are no approved pharmacotherapies for addiction to cocaine and other
psychostimulant drugs. Several studies have proposed that cannabidiol (CBD) could be a …

Cocaine use entails severe health-and social-related harms globally. Treatment options for
cocaine dependence are highly limited. Benefits of cannabinoids for addiction have been …

Introduction Cannabidiol (CBD) is a phytocannabinoid found in the Cannabis plant. CBD
has received significant medical attention in relation to its anticonvulsant, anxiolytic, and …